These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34449152)

  • 1. Clinical and molecular characteristics of carnitineacylcarnitine translocase deficiency with c.270delC and a novel c.408C>A variant.
    Gürbüz BB; Yılmaz DY; Özgül RK; Koşukcu C; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Turk J Pediatr; 2021; 63(4):691-696. PubMed ID: 34449152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review.
    Yan HM; Hu H; Ahmed A; Feng BB; Liu J; Jia ZJ; Wang H
    Medicine (Baltimore); 2017 Nov; 96(45):e8549. PubMed ID: 29137068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characteristics of carnitine-acylcarnitine translocase deficiency: Experience with six patients in Guangdong China.
    Tang C; Liu S; Wu M; Lin S; Lin Y; Su L; Zhang J; Feng Y; Huang Y
    Clin Chim Acta; 2019 Aug; 495():476-480. PubMed ID: 31108048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine-acylcarnitine translocase deficiency caused by
    Zhang L; Hu Y; Xie M; Zhang Y; Cen K; Chen L; Cui Y; Li H; Wang D
    J Int Med Res; 2023 Apr; 51(4):3000605231163811. PubMed ID: 37115522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-Onset Carnitine-Acylcarnitine Translocase Deficiency With
    Chen M; Cai Y; Li S; Xiong H; Liu M; Ma F; Xiao X; Hao H
    Front Pediatr; 2020; 8():585646. PubMed ID: 33194920
    [No Abstract]   [Full Text] [Related]  

  • 6. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
    Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
    Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
    Chalmers RA; Stanley CA; English N; Wigglesworth JS
    J Pediatr; 1997 Aug; 131(2):220-5. PubMed ID: 9290607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: Management challenges and potential therapeutic approaches.
    Ryder B; Inbar-Feigenberg M; Glamuzina E; Halligan R; Vara R; Elliot A; Coman D; Minto T; Lewis K; Schiff M; Vijay S; Akroyd R; Thompson S; MacDonald A; Woodward AJM; Gribben JEL; Grunewald S; Belaramani K; Hall M; van der Haak N; Devanapalli B; Tolun AA; Wilson C; Bhattacharya K
    J Inherit Metab Dis; 2021 Jul; 44(4):903-915. PubMed ID: 33634872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal sudden death caused by a novel heterozygous mutation in SLC25A20 gene: A case report and brief literature review.
    Li X; Zhao F; Zhao Z; Zhao X; Meng H; Zhang D; Zhao S; Ding M
    Leg Med (Tokyo); 2022 Feb; 54():101990. PubMed ID: 34784499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of four carnitine-acylcarnitine translocase deficiency cases caused by homozygous mutation of SLC25A20 c.199-10T> G].
    Fan X; Xie BB; Zhang Q; Yi S; Geng GX; Yang Q; Luo JS; Wang J; Li C; Chen SK; Shen YP
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):545-549. PubMed ID: 29996190
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.
    Iacobazzi V; Invernizzi F; Baratta S; Pons R; Chung W; Garavaglia B; Dionisi-Vici C; Ribes A; Parini R; Huertas MD; Roldan S; Lauria G; Palmieri F; Taroni F
    Hum Mutat; 2004 Oct; 24(4):312-20. PubMed ID: 15365988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing analysis in a couple with three children who died prematurely due to carnitine-acylcarnitine translocase deficiency.
    Tran VK; Diep QM; Qiu Z; Le TP; Do LD; Tran HA; Bui TH; Ta TV; Tran TH
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):153-156. PubMed ID: 35181030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular in vitro probe acylcarnitine assay for identifying deficiencies of carnitine transporter and carnitine palmitoyltransferase-1.
    Purevsuren J; Kobayashi H; Hasegawa Y; Yamada K; Takahashi T; Takayanagi M; Fukao T; Fukuda S; Yamaguchi S
    Anal Bioanal Chem; 2013 Feb; 405(4):1345-51. PubMed ID: 23143007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.
    Wang GL; Wang J; Douglas G; Browning M; Hahn S; Ganesh J; Cox S; Aleck K; Schmitt ES; Zhang W; Wong LJ
    Mol Genet Metab; 2011 Aug; 103(4):349-57. PubMed ID: 21605995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
    Röschinger W; Muntau AC; Duran M; Dorland L; IJlst L; Wanders RJ; Roscher AA
    Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia.
    Habib A; Azize NAA; Rahman SA; Yakob Y; Suberamaniam V; Nazri MIBA; Abdullah Sani H; Ch'ng GS; Yin LH; Olpin S; Lock-Hock N
    Clin Biochem; 2021 Dec; 98():48-53. PubMed ID: 34626609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China.
    Zhou D; Cheng Y; Yin X; Miao H; Hu Z; Yang J; Zhang Y; Wu B; Huang X
    Front Genet; 2022; 13():823687. PubMed ID: 35360862
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal hyperammonemia caused by a defect of carnitine-acylcarnitine translocase.
    Ogier de Baulny H; Slama A; Touati G; Turnbull DM; Pourfarzam M; Brivet M
    J Pediatr; 1995 Nov; 127(5):723-8. PubMed ID: 7472823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation.
    Iacobazzi V; Pasquali M; Singh R; Matern D; Rinaldo P; Amat di San Filippo C; Palmieri F; Longo N
    Am J Med Genet A; 2004 Apr; 126A(2):150-5. PubMed ID: 15057979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.